Delaying MVA Induced Apoptosis For Enhancing Immunogenicity (B13R)
US Application 62/402,669
Filed on 2016-09-30
Filed on 2016-09-30
NOVEL RECOMBINANT PREFUSION RSV F PROTEINS AND USES THEREOF
US Application 62/435,275
Filed on 2016-12-16
Filed on 2016-12-16
NEUTRALIZING ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN AND THEIR USE
US Application 62/612,982
Filed on 2018-01-02
Filed on 2018-01-02
Glycan-Masked Engineered Outer Domains of HIV-1 GP120 and Their Use
US Application 62/476,397
Filed on 2017-03-24
Filed on 2017-03-24
ZIKA VIRUS VACCINES
US Application 62/461,095
Filed on 2017-02-20
Filed on 2017-02-20
NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE
US Application 62/457,720
Filed on 2017-02-10
Filed on 2017-02-10
Trispecific Binding Protein
US Application 62/246,113
Filed on 2015-10-25
Filed on 2015-10-25
Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection
US Application 62/331,169
Filed on 2016-05-03
Filed on 2016-05-03
Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection
US Application 62/322,029
Filed on 2016-04-13
Filed on 2016-04-13